Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
about
TIM-3 Regulates Distinct Functions in MacrophagesRole of Tim-3 in hepatitis B virus infection: An overviewBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsEmerging and Novel Functions of Complement Protein C1qDendritic cell-based immunity and vaccination against hepatitis C virus infectionInterleukin 12: still a promising candidate for tumor immunotherapy?Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infectionProduction and pathogenicity of hepatitis C virus core gene products.Synergistic effect of IL-12 and IL-18 induces TIM3 regulation of γδ T cell function and decreases the risk of clinical malaria in children living in Papua New GuineaTim-3 and its role in regulating anti-tumor immunity.A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection.Cis association of galectin-9 with Tim-3 differentially regulates IL-12/IL-23 expressions in monocytes via TLR signalingTim-3 protects decidual stromal cells from toll-like receptor-mediated apoptosis and inflammatory reactions and promotes Th2 bias at the maternal-fetal interface.Alcohol-induced miR-27a regulates differentiation and M2 macrophage polarization of normal human monocytes.Up-regulation of A20/ABIN1 contributes to inefficient M1 macrophage polarization during Hepatitis C virus infection.The Tim3-galectin 9 pathway induces antibacterial activity in human macrophages infected with Mycobacterium tuberculosisDifferential regulation of interleukin-12 (IL-12)/IL-23 by Tim-3 drives T(H)17 cell development during hepatitis C virus infection.KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.HCV core protein binds to gC1qR to induce A20 expression and inhibit cytokine production through MAPKs and NF-κB signaling pathways.Tim-3: an activation marker and activation limiter of innate immune cellsT cell immunoglobulin and mucin domain-containing molecule 3 on CD14+ monocytes serves as a novel biological marker for diabetes duration in type 2 diabetes mellitus.Enhanced virus-specific CD8+ T cell responses by Listeria monocytogenes-infected dendritic cells in the context of Tim-3 blockadeTIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action.Hepatitis C virus-mediated modulation of cellular immunity.Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection.Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion.Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies.Human galectin-9 on the porcine cells affects the cytotoxic activity of M1-differentiated THP-1 cells through inducing a shift in M2-differentiated THP-1 cells.T-bet-mediated Tim-3 expression dampens monocyte function during chronic hepatitis C virus infection.Hepatitis A virus cellular receptor 2 (HAVCR2) is decreased with viral infection and regulates pro-labour mediators OA.MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.Tim-3 suppression combined with TLR3 activation enhances antiviral immune response in patients with chronic HCV infection.HCV-induced miR146a controls SOCS1/STAT3 and cytokine expression in monocytes to promote regulatory T-cell development.Plasma soluble Tim-3 emerges as an inhibitor in sepsis: sepsis contrary to membrane Tim-3 on monocytes.Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection.HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.Role of A20 in interferon-α-mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C.Lipoarabinomannan Decreases Galectin-9 Expression and Tumor Necrosis Factor Pathway in Macrophages Favoring Mycobacterium tuberculosis Intracellular Growth.Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma.
P2860
Q26744557-ABE36071-55D3-4132-AAFC-3C3414DA8200Q26768530-E3211D06-5112-4847-B257-34E68EDE6EECQ26782799-79CADA63-737C-45C9-9D22-18163CC1A5C3Q26801642-B337A66F-18D0-4A42-A9DE-929A651C9060Q26828003-BF02C671-20BD-4FD5-BD16-790599788653Q26861559-A68F4DE7-4BB1-47A5-AA21-AC970947747DQ28506567-27B18126-D814-46F4-A2B8-80BDEE869919Q33780095-E68587B6-DB99-48C9-B71B-ECFCCC8AAE11Q33802385-A3D53922-3E16-411D-B8CD-252B3A53CD24Q33909020-33BAA49A-0AAA-46FD-AFB3-06C6CAF02B59Q34744674-37217DD5-66B0-4873-AA14-7F1F9BCFC5F2Q34965205-5602334C-F85A-468A-BB1F-521EDEA91B23Q35165802-AA98F6D5-4901-4C57-90F5-9370E0DC0937Q35896589-71F0DFC3-F859-45A5-9176-327867EA9BEFQ36071847-1B84DCCE-7664-4CBF-AB4A-D367E8650F31Q36451717-C6898A43-A7DF-4BE3-B5A6-470A693B2FF0Q36760150-AA329AEE-C88C-4713-906B-2F34E9EF9803Q37252732-AD111C8F-98A7-4963-8652-10F800FE0F17Q37376151-AD770C37-C509-4E25-A64A-80E2561644BFQ37379212-775E2623-F1A0-4230-9A42-6A5EB457FA30Q37385510-F7F868EE-8563-4978-A9DE-BD9EE0057F96Q37539241-5B4FC820-C54C-4427-BBAA-E1A01C889A55Q37729313-42BA9144-830A-4A92-B972-50CB897EFEB5Q38036576-D1F874A5-56DF-40BF-8F6A-E23C2FDF88BEQ38080732-01F2B911-213F-47B8-8B0A-9580111F2BD0Q38223279-081E5D5E-4A10-43A5-80C8-FEF111C1F9F8Q38236249-76EA6359-3BB1-4701-8CF7-D3F04F367716Q38472322-9171748D-10DB-4924-B2FA-66741CBBB64CQ38706495-B97D0C2C-B9CA-4816-B082-F359458CCD0AQ38733708-4AF07A45-3667-4C86-AA39-7393FEA22CE3Q38807353-4E0A6541-C7FB-4430-A764-79BB59858E6BQ38899741-7B94DA60-1075-4735-A0FF-A530229D0FD2Q40688859-45D7FCD0-7241-4AC6-B557-851CD94229C9Q40745016-FC8EB8BD-2E0F-4ADA-ADFA-CC617524AAACQ40997923-3C9C3C88-497B-45B1-BAB5-B05FE6101369Q41198488-77FF4D5E-90AC-4928-AA0D-039198A11F5BQ41894013-8A4BE3F3-2104-4EB2-AB4D-D1CE0CC2BBC6Q42208901-8D219AF1-B3F5-4F02-B725-3C07C42ECE96Q47098248-A6191D6F-2DCC-45D6-8FBD-1358854E0DA2Q47554770-3D3A95D6-76FF-49D5-806D-DD0641224215
P2860
Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
@ast
Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
@en
type
label
Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
@ast
Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
@en
prefLabel
Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
@ast
Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
@en
P2093
P2860
P1433
P1476
Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
@en
P2093
Cheng J Ma
Jia M Wang
Jonathan P Moorman
Ying Zhang
Zhan S Jia
P2860
P304
P356
10.1371/JOURNAL.PONE.0019664
P407
P577
2011-05-26T00:00:00Z